Recent Finacing
Recent Raise
Noveome is a clinical-stage biopharmaceutical developing a non-cellular biologic platform (lead product ST266) restoring cellular integrity in CNS and ophthalmic indications, with ongoing Ph1 intranasal and Ph2 corneal trials.